This text investigates the rapid development of antiviral chemotherapy as a primary medical intervention against viral infections. Authors Richard Challand and Robert J. Young synthesize recent breakthroughs in viral genetics and protein functionality to explain how these discoveries translate into clinical drug therapies. The book provides a structured overview of the biochemical mechanisms that allow modern medicine to target specific viral pathogens effectively.

Experts recognize this volume as a foundational introduction to the field of antiviral drug development. Readers frequently note the technical clarity of the prose, which bridges the gap between complex biochemical research and practical medicinal application.